Gut microbiome and diabetes: Emerging perspectives in metabolic regulation
Scripta Medica · 2026 · 57 (3) · 661-674
DOI: 10.5937/scriptamed57-61236 ↗At a glance
Journal article in Scripta Medica, 2026. Written by Navreet Kaur and 3 co-authors. 122 references. The full text is freely available (open access, CC BY 4.0).
Topics: Diabetes mellitus
Abstract (original language)
Diabetes mellitus type 2 (T2DM) is one of the fastest-growing metabolic disorders in the world. It is marked by insulin resistance, high blood sugar and high cholesterol levels. Recently, its prevalence has increased significantly, making it a major health issue globally. New evidence shows that people with T2DM often have changes in their gut microbiota composition and suffer from problems in multiple organ systems. This review focused on the changes in gut microbiota related to T2DM and examined how microbial byproducts affect the disease's development. The potential for identifying at-risk individuals based on microbial patterns and the creation of specific treatments was also discussed. Lastly, it was looked into gut health strategies that aim to change the gut microbiota to prevent or slow the advancement of T2DM.
Cite
APA
Kaur, N., Kaur, N., Verma, A., & Kumar, S. (2026). Gut microbiome and diabetes: Emerging perspectives in metabolic regulation. Scripta Medica, 57(3), 661-674. https://doi.org/10.5937/scriptamed57-61236
Vancouver
Kaur N, Kaur N, Verma A, Kumar S. Gut microbiome and diabetes: Emerging perspectives in metabolic regulation. Scripta Medica. 2026;57(3):661-674. doi:10.5937/scriptamed57-61236
BibTeX
@article{Kaur2026,
author = {Kaur, Navreet and Kaur, Navjot and Verma, Aanchal and Kumar, Sharma},
title = {Gut microbiome and diabetes: Emerging perspectives in metabolic regulation},
journal = {Scripta Medica},
year = {2026},
volume = {57},
number = {3},
pages = {661--674},
doi = {10.5937/scriptamed57-61236}
}
EUVIMED